EYSUVIS FDA approval date

The FDA approved EYSUVIS on 26 Oct 2020.

FDA approval date
26 Oct 2020

Drug identity has not yet been verified against registry records

Also recorded as LOTEPREDNOL ETABONATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-10-26DayEYSUVISFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210933", "applicant_as_listed_by_fda": "ALCON LABS INC", "brand_names": ["EYSUVIS"], "active_ingredients": ["LOTEPREDNOL ETABONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20201026", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026